Call for patient input on a submission from UCB for brivaracetam

17 March 2016 - CADTH has received notice of a pending submission from UCB for brivaracetam for the treatment of patients with partial-onset seizures.

For more details, go to: https://www.cadth.ca/brivaracetam

Michael Wonder

Posted by:

Michael Wonder